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The ability to reprogram differentiated cells to pluripotency has revolutionized stem cell
research and provides the foundation for new approaches to model human disease and
possible stem cell-based therapies for degenerative diseases. To fully exploit this potential it
will be necessary to develop simpler and more efficient ways to generate induced pluripotent
stem (iPS) cells. Anokye-Danso and colleagues present a novel strategy for generating
human and mouse iPS cells that is quicker and 100-fold more efficient than conventional
protocols1. Remarkably, unlike all previous reports that use transcription factors, their
approach uses only microRNAs (miRNAs)2. So how do these miRNAs accomplish this
amazing feat? Subramanyam et al., shed some light on this question and identify a set of
miRNA target genes that when depleted can facilitate iPS cell formation3. Together these
studies highlight the utility of miRNAs in both iPS generation as well as dissecting the
mechanisms and pathways underlying cell reprogramming.
The groundbreaking findings that differentiated can be reprogrammed to iPS cells by
enforced expression of a few defined factors (Oct3/4, Sox2, Klf4, and c-Myc (OSKM))
overcomes many of the technical, ethical, and political obstacles in human embryonic stem
cell (ESC) research and regenerative medicine4. iPS cells represent an alternative source of
pluripotent cells for possible therapeutic applications. However, the initial reprogramming
efficiencies were low (less than 0.1%) and the original cocktail of reprogramming factors
includes oncogenes that can lead to tumorigenesis4. Also, retroviral infection of the target
cells causes multiple potentially harmful integrations of the transgenes into the host genome.
Since then, efforts to refine and develop alternative approaches include the use of non-
integrating systems to deliver the reprogramming genes, and the replacement of individual
factors with small molecules5. However, common to all of these is the use of at least one
transcription factor, usually Oct3/42.
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miRNAs in this process is much less well understood. miRNAs represent a large family of
regulatory RNAs that posttranscriptionally repress the expression of large sets of target
genes and are essential for normal development and ESC biology6. Importantly, ESCs
express a unique a set of miRNAs with the majority transcribed from two genomic loci, the
miR-302 cluster (that contains five miRNAs – miR-302a/b/c/d and miR-367) and the
miR-290 cluster in mice (miR-290, miR-291a, miR-292, miR-291b, miR-293, miR-294, and
miR-295) or the miR-371-373 cluster in humans (miR-371, miR-372 and miR-373). ESC-
specific miRNAs share a very similar ‘Seed’ sequence and therefore likely regulate
overlapping sets of target genes. These miRNAs are required rapid ESC proliferation and
cell-cycle progression6. Previous studies indicated that the miRNA pathway could be
exploited for cell reprogramming7,8. Introduction of individual members of the miR-290
cluster or miR-302 was found to enhance cell reprogramming by OSK, but not by OSKM8.
More recently however, it was demonstrated that miRNAs enhance reprogramming of MEFs
with either OSKM or OSK. Furthermore, antagonizing these miRNAs with antisense
oligonucleotides conversely inhibited reprogramming9.
An exciting new study demands close attention because instead of using any of the standard
OSKM transcription factors the authors simply express a single primary miRNA transcript
(the miR-302/367 cluster) to reprogram mouse and human somatic cells1. Importantly the
resulting iPS cells exhibit gene expression and functional properties characteristic of fully
reprogrammed pluripotent cells. Remarkably, the reprogramming, mediated by
miR-302/367, is 100-fold more efficient than with OSKM, with ~10% of fibroblasts forming
iPS colonies. Furthermore, the temporal kinetics of reprogramming may also be accelerated.
Though this approach works for both mouse and human cells, valporic acid (VPA) was
required for reprogramming mouse cells and was administered in conjunction with the
miRNA-expressing virus. Interestingly, reprogramming of human cells did not require VPA
and the miRNAs alone were sufficient for efficient reprogramming. So what is the
difference for the species-specific requirement for VPA? It seems that a key barrier to
reprogramming is the histone deacetylase, HDAC2, which is targeted for destruction by
VPA and is expressed at considerably higher levels in mouse compared to human
fibroblasts. Accordingly, reprogramming of mouse HDAC2−/− MEFs did not require VPA
and miR-302/367 alone could efficiently reprogram these cells.
What is the mechanism behind miRNA-mediated cell reprogramming? miRNAs commonly
target a large group of mRNAs simultaneously, and the combinatorial regulation of more
than a handful of genes is likely required for cell reprogramming. The demonstration that
ESC miRNAs enhance reprogramming, strongly suggests that these miRNAs are
functioning to repress expression of genes that would otherwise work to maintain the
differentiated cell state and may therefore represent barriers to reprogramming. Using this
rationale, the Blelloch laboratory began to address the mechanism by which ESC miRNAs
enhance reprogramming3. Using synthetic miRNA mimics, they find that introduction of
miR-302b or miR-372 can enhance both OSKM- and OSK-mediated reprogramming of
human fibroblasts. Next, using a published data set they chose a group of around thirty
potential miR-302/miR-372 target genes for further analysis7. From this list they focus on a
subset of twelve genes that respond to miRNA expression in the context of reprogramming.
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tImportantly, they use siRNAs to individually deplete each of these putative miRNA targets
and measure the effect on reprogramming. They show that knockdown of three of these
genes (RBl2, CDC2L, and RHOC) enhances reprogramming both with OSKM and with
OSK. They find that individual depletion of an additional three genes (SMARCC2, MBD2,
and MECP2) enhances reprogramming in one of the two conditions (i.e. either OSKM or
OSK). Since the gene encoding the TGFß receptor, TGFBR2, was among the selected gene
set they use a small molecule inhibitor to confirm the involvement of this signaling pathway.
They find that TGFBR2 mRNA is directly repressed by these miRNAs. Mouse Tgfbr2 is
also regulated by similar miRNAs and siRNA-mediated knockdown of Tgfbr2 enhances
reprogramming of MEFs9. The evolutionarily conserved requirement for the TGFß receptor
further supports data that a mesenchymal-epithelial transition (MET) accompanies human
cell reprogramming as it does in mouse. Importantly, since inhibition of any single gene led
to relatively modest enhancement in cell reprogramming compared to the effects of the
miRNA itself, as well as the increased efficiency observed by the simultaneous inhibition of
more than one pathway, support the notion that miRNAs promote reprogramming by
targeting multiple genes in several different downstream pathways (Figure 1).
These studies illuminate some of the genes that are targeted by the ESC-specific miRNAs in
the context of reprogramming and demonstrate the remarkable power of miRNAs to
efficiently reprogram cells to pluripotency1,3,8,9. Both miR-302 and miR-367 are required
for iPS cell formation1. What genes are repressed by miR-367 to promote reprogramming?
This missing piece of the puzzle remains to be addressed. However, a highly related
miRNA, miR-92b, represses expression of Cdkn1c (p57) and is important for cell cycle
progression of human ESCs10. Therefore it is likely that miR-367 facilitates reprogramming
at least in part by modulating cell proliferation.
An obvious next experiment is to try and replace the viral delivery of the miRNA transgene.
Since Morrisey’s lab showed that miR-367 is essential for miRNA-mediated reprogramming
it will be interesting to see whether adding this synthetic miRNA to those used in the
Blelloch study will enable the generation of iPS cells without the need for viruses or genome
integration1,3. miRNAs may prove particularly useful in this regard since they are small and
easily synthesized. Moreover, they are relatively easily transfected into cells and do not
stimulate an innate immune response in the host cell. Furthermore, once incorporated into
the relevant ribonucleoprotein complexes they are relatively stable with a reported half-life
of several days in cells. These properties, together with the breakthrough proof-of-concept
experiments, identify miRNAs as perhaps the ideal mode for reprogramming human cells
and may help unleash the therapeutic potential of iPS cells.
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tFigure 1. How do miRNAs reprogram mouse and human cells to pluripotency?
Differentiated cells can be reprogrammed to iPS cells by expressing the miR-302/367 cluster
of miRNAs. For mouse cells valproic acid (VPA) is additionally required. Multiple
downstream target genes and pathways have been identified for miR-302. miR-367 is
essential for reprogramming and Oct4 activation however targets of this miRNA remain
unknown.
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